Please try another search
Obio Technology (Shanghai) Corp., Ltd., a biotechnology company, focuses on the development of gene therapy vectors in China. The company provides gene function and gene therapy research, and other CRO services, such as drug target and drug efficacy research. It also offers CDMO services, such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs. The company was founded in 2013 and is headquartered in Shanghai, China.
Name | Age | Since | Title |
---|---|---|---|
Oudong Pan | - | - | Founder & Chairman of the Board |
Kejia Yuan | 40 | 2020 | Director |
Guodong Jia | 43 | 2020 | GM & Director |
Long Xia | 37 | 2022 | Director |
Gang Wang | 67 | 2020 | Independent Director |
Junyi Pan | 30 | - | Investment Director & Director |
Shan Yin | 42 | 2015 | Deputy GM & Director |
Fujie Wang | 49 | - | VP of Supply Chain & Information Technology and Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review